Cargando…

Breast cancer brain metastases: biology and new clinical perspectives

Because of improvements in the treatment of patients with metastatic breast cancer, the development of brain metastases (BM) has become a major limitation of life expectancy and quality of life for many breast cancer patients. The improvement of management strategies for BM is thus an important clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Witzel, Isabell, Oliveira-Ferrer, Leticia, Pantel, Klaus, Müller, Volkmar, Wikman, Harriet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717619/ https://www.ncbi.nlm.nih.gov/pubmed/26781299 http://dx.doi.org/10.1186/s13058-015-0665-1

Ejemplares similares

Brain Metastasis in Breast Cancer Patients—Need for Improvement
por: Witzel, Isabell, et al.
Publicado: (2020)

Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases
por: Wikman, Harriet, et al.
Publicado: (2012)

Molecular Mechanisms Associated with Brain Metastases in HER2-Positive and Triple Negative Breast Cancers
por: Bryan, Sarah, et al.
Publicado: (2021)

Insights into the Steps of Breast Cancer–Brain Metastases Development: Tumor Cell Interactions with the Blood–Brain Barrier
por: Hamester, Fabienne, et al.
Publicado: (2022)

Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer
por: Hamester, Fabienne, et al.
Publicado: (2022)

PTEN mediates the cross talk between breast and glial cells in brain metastases leading to rapid disease progression
por: Hohensee, Ina, et al.
Publicado: (2016)

Clonality of circulating tumor cells in breast cancer brain metastasis patients
por: Riebensahm, Carlotta, et al.
Publicado: (2019)

Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
por: Eichelser, Corinna, et al.
Publicado: (2014)

Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients
por: Wikman, Harriet, et al.
Publicado: (2014)

Interplay of lncRNA H19/miR‐675 and lncRNA NEAT1/miR‐204 in breast cancer
por: Müller, Volkmar, et al.
Publicado: (2019)

The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients
por: Reimer, Francesca, et al.
Publicado: (2023)

Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2020)

Characteristics and Clinical Outcome of Breast Cancer Patients with Asymptomatic Brain Metastases
por: Laakmann, Elena, et al.
Publicado: (2020)

Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients
por: Ni, Qingtao, et al.
Publicado: (2018)

Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry
por: Laakmann, Elena, et al.
Publicado: (2016)

Author Correction: Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients
por: Ni, Qingtao, et al.
Publicado: (2019)

Stromal Caveolin-1 and Caveolin-2 Expression in Primary Tumors and Lymph Node Metastases
por: Gerstenberger, Wladimir, et al.
Publicado: (2018)

PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial‐mesenchymal transition in cultured breast cancer cells
por: Lehtinen, Laura, et al.
Publicado: (2017)

Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives
por: Müller, Volkmar, et al.
Publicado: (2004)

Relevance of PTEN loss in brain metastasis formation in breast cancer patients
por: Wikman, Harriet, et al.
Publicado: (2012)

Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
por: Keller, Laura, et al.
Publicado: (2020)

Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions
por: Herbst, Johanna, et al.
Publicado: (2022)

Tumor-Stroma Interaction in PDAC as a New Approach for Liquid Biopsy and its Potential Clinical Implications
por: Götze, Julian, et al.
Publicado: (2022)

Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance
por: Fehm, Tanja, et al.
Publicado: (2008)

Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression
por: Bednarz-Knoll, Natalia, et al.
Publicado: (2015)

Exosomal microRNAs as tumor markers in epithelial ovarian cancer
por: Pan, Chi, et al.
Publicado: (2018)

Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer
por: Legler, Karen, et al.
Publicado: (2018)

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015)

Recent translational research: circulating tumor cells in breast cancer patients
por: Müller, Volkmar, et al.
Publicado: (2006)

Spine Metastases in Immunocompromised Mice after Intracardiac Injection of MDA-MB-231-SCP2 Breast Cancer Cells
por: Brylka, Laura, et al.
Publicado: (2022)

Circulating Tumour Cell Release after Cement Augmentation of Vertebral Metastases
por: Mohme, Malte, et al.
Publicado: (2017)

Iroquois homeobox 2 suppresses cellular motility and chemokine expression in breast cancer cells
por: Werner, Stefan, et al.
Publicado: (2015)

Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
por: Aktas, Bahriye, et al.
Publicado: (2016)

Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis
por: Kempska, Joanna, et al.
Publicado: (2023)

Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2017)

Emerging Insights into Keratin 16 Expression during Metastatic Progression of Breast Cancer
por: Elazezy, Maha, et al.
Publicado: (2021)

Adaptation and qualitative evaluation of encounter decision aids in breast cancer care
por: Hahlweg, Pola, et al.
Publicado: (2019)

Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores
por: Riecke, Kerstin, et al.
Publicado: (2021)

Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease
por: Hanssen, Annkathrin, et al.
Publicado: (2018)

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tu5cdcb957693skj6rjiefb9d2